S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:SOL

Emeren Group (SOL) Stock Price, News & Analysis

$1.72
-0.02 (-1.15%)
(As of 04/19/2024 ET)
Today's Range
$1.70
$1.77
50-Day Range
$1.74
$2.37
52-Week Range
$1.54
$4.28
Volume
339,870 shs
Average Volume
558,634 shs
Market Capitalization
$103.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.80

Emeren Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
240.2% Upside
$5.80 Price Target
Short Interest
Healthy
3.06% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Emeren Group in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
65.79%
From $0.38 to $0.63 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.31 out of 5 stars

Oils/Energy Sector

108th out of 230 stocks

Semiconductors & Related Devices Industry

39th out of 88 stocks

SOL stock logo

About Emeren Group Stock (NYSE:SOL)

Emeren Group Ltd, through its subsidiaries, develops, builds, operates, and sells solar power projects. It owns and operates 3 gigawatt pipeline of projects and independent power producer assets. The company also develops community solar gardens; and sells project rights. In addition, it engages in engineering design; procurement of solar modules; balance-of-system components and other components; and construction contracting and management services. Further, the company generates and sells electricity. It operates in China, United States, UK, Spain, France, Poland, Italy, Hungary, and Internationally. The company was formerly known as ReneSola Ltd and changed its name to Emeren Group Ltd in January 2023. Emeren Group Ltd was founded in 2005 and is headquartered in Stamford, Connecticut.

SOL Stock Price History

SOL Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Emeren Group Ltd ADR
Emeren Group: Over-Optimism Should Be Set Aside
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Earnings Outlook For Emeren Group
SOL Jul 2024 2.500 call
SOL Apr 2024 5.000 put
See More Headlines
Receive SOL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emeren Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/07/2021
Today
4/19/2024
Next Earnings (Estimated)
5/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Semiconductors & related devices
Sub-Industry
N/A
Employees
197
Year Founded
2005

Price Target and Rating

Average Stock Price Target
$5.80
High Stock Price Target
$8.00
Low Stock Price Target
$3.20
Potential Upside/Downside
+240.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-9,320,000.00
Pretax Margin
-2.19%

Debt

Sales & Book Value

Annual Sales
$104.67 million
Cash Flow
$0.17 per share
Book Value
$6.45 per share

Miscellaneous

Free Float
49,372,000
Market Cap
$102.68 million
Optionable
Optionable
Beta
1.78

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Yumin Liu (Age 61)
    CEO & Director
  • Mr. Ke Chen (Age 50)
    Chief Financial Officer
  • Mr. Chee Loong Cheah (Age 59)
    Chief Investment Officer & Executive VP of Europe
  • Mr. Johnny Pan
    Investor Relations
  • Xin Wang
    Compliance Director
  • Jake Snow
    Human Resources Director
  • Mr. Mac Moore
    Interim Executive Vice President of North America
  • Mr. KaiKai Zhang
    Interim Executive Vice President of China
  • Suzanne Wilson
    Secretary to the Board
  • Fei Wang
    Vice President of Finance

SOL Stock Analysis - Frequently Asked Questions

Should I buy or sell Emeren Group stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Emeren Group in the last year. There are currently 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SOL shares.
View SOL analyst ratings
or view top-rated stocks.

What is Emeren Group's stock price target for 2024?

4 Wall Street research analysts have issued 1-year target prices for Emeren Group's stock. Their SOL share price targets range from $3.20 to $8.00. On average, they expect the company's stock price to reach $5.80 in the next year. This suggests a possible upside of 240.2% from the stock's current price.
View analysts price targets for SOL
or view top-rated stocks among Wall Street analysts.

How have SOL shares performed in 2024?

Emeren Group's stock was trading at $2.73 on January 1st, 2024. Since then, SOL stock has decreased by 37.5% and is now trading at $1.7050.
View the best growth stocks for 2024 here
.

When is Emeren Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024.
View our SOL earnings forecast
.

How were Emeren Group's earnings last quarter?

Emeren Group Ltd (NYSE:SOL) posted its quarterly earnings data on Tuesday, December, 7th. The semiconductor company reported $0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.03. The semiconductor company had revenue of $15.54 million for the quarter, compared to analysts' expectations of $20.22 million. Emeren Group had a negative net margin of 8.91% and a positive trailing twelve-month return on equity of 0.26%. During the same quarter in the previous year, the company posted $0.05 EPS.

What ETF holds Emeren Group's stock?

ProShares S&P Kensho Cleantech ETF holds 17,217 shares of SOL stock, representing 1.00% of its portfolio.

When did Emeren Group's stock split?

Emeren Group shares reverse split on Friday, February 10th 2017. The 1-5 reverse split was announced on Monday, January 30th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What guidance has Emeren Group issued on next quarter's earnings?

Emeren Group updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of 0.500- for the period, compared to the consensus earnings per share estimate of 0.350. The company issued revenue guidance of $150.0 million-$160.0 million, compared to the consensus revenue estimate of $148.7 million.

What is Xian Shou Li's approval rating as Emeren Group's CEO?

34 employees have rated Emeren Group Chief Executive Officer Xian Shou Li on Glassdoor.com. Xian Shou Li has an approval rating of 28% among the company's employees. This puts Xian Shou Li in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Emeren Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emeren Group investors own include Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Nokia Oyj (NOK), FuelCell Energy (FCEL), Advanced Micro Devices (AMD), SunPower (SPWR), VBI Vaccines (VBIV), First Solar (FSLR), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

How do I buy shares of Emeren Group?

Shares of SOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Emeren Group have any subsidiaries?
The following companies are subsidiares of Emeren Group: ET Cap PA Holdings LLC (“PA Holdings”) and ET Cap CA Holdings LLC (“CA Holdings”), Nova Development Management, RE PV S.à r.l., RENESOLA SPAIN S.L., ReneSola Consulting (Shanghai) Co. Ltd, ReneSola Investment Management Ltd., ReneSola New Energy S.à r.l, ReneSola Power Canada, ReneSola Power Holdings LLC., Renesola (Zhejiang) PV Power Co.  Ltd., Renesola Germany GmbH, Renesola Poksla sp. z o.o., Renesola Power Italy, Renesola Power UK LTD, Renesola Szolgáltató és Kivitelező Kft., Renesolapower France, Sichuan Bobo Electric Power Engineering Ltd., and Zhejiang ReneSola Investment Ltd.
Read More
This page (NYSE:SOL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners